Explore more publications!
Tech Times of New York
Got News to Share?

Tech Times of New York: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Tech Times of New York.

December 2025

Mo Tu We Th Fr Sa Su
1 2 3 4 5 6 7
8 9 10 11 12 13 14
15 16 17 18 19 20 21
22 23 24 25 26 27 28
29 30 31

January 2026

Mo Tu We Th Fr Sa Su
1 2 3 4
5 6 7 8 9 10 11
12 13 14 15 16 17 18
19 20 21 22 23 24 25
26 27 28 29 30 31

February 2026

Mo Tu We Th Fr Sa Su
1
2 3 4 5 6 7 8
9 10 11 12 13 14 15
16 17 18 19 20 21 22
23 24 25 26 27 28

Press releases published on November 9, 2025

ZETIC.ai Launches MLange, the First One-Stop On-Device AI App Development Platform
Nov. 9, 2025

ZETIC.ai Launches MLange, the First One-Stop On-Device AI App Development Platform

Indeterminate EIN Presswire
Antony Goddard of OKKAMI Featured on Forbes: “Beyond The Chatbot – Using AI and Data to Redefine Hospitality”
Nov. 9, 2025

Antony Goddard of OKKAMI Featured on Forbes: “Beyond The Chatbot – Using AI and Data to Redefine Hospitality”

Indeterminate EIN Presswire
Faraday Future Founder and Co-CEO YT Jia Shares Weekly Investor Update: FX Super One Planned to Enter the Pilot Build and Production Phase at its Hanford Manufacturing Facility as First Batch of Complete Sets of Parts Scheduled to Arrive in the U.S. as…
Nov. 9, 2025

Faraday Future Founder and Co-CEO YT Jia Shares Weekly Investor Update: FX Super One Planned to Enter the Pilot Build and Production Phase at its Hanford Manufacturing Facility as First Batch of Complete Sets of Parts Scheduled to Arrive in the U.S. as…

Indeterminate GlobeNewswire
AVITA Medical to Host Investor Webinar Briefing
Nov. 9, 2025

AVITA Medical to Host Investor Webinar Briefing

Indeterminate GlobeNewswire
New REDUCE-IT® Aspirin Analysis Presented at AHA Scientific Sessions 2025 Reinforces VASCEPA®/VAZKEPA® (Icosapent Ethyl) Reduced Cardiovascular Events in High-Risk Patients
Nov. 9, 2025

New REDUCE-IT® Aspirin Analysis Presented at AHA Scientific Sessions 2025 Reinforces VASCEPA®/VAZKEPA® (Icosapent Ethyl) Reduced Cardiovascular Events in High-Risk Patients

Indeterminate GlobeNewswire
TLX Investor News: If You Have Suffered Losses in Telix Pharmaceuticals Ltd. (NASDAQ: TLX), You Are Encouraged to Contact The Rosen Law Firm About Your Rights
Nov. 9, 2025

TLX Investor News: If You Have Suffered Losses in Telix Pharmaceuticals Ltd. (NASDAQ: TLX), You Are Encouraged to Contact The Rosen Law Firm About Your Rights

Indeterminate GlobeNewswire
AHA 2025: Late-Breaking Data Reinforce the Prognostic Power of AI-Driven Heartflow Plaque Analysis as the Most Clinically Validated Framework for Coronary Risk Stratification
Nov. 9, 2025

AHA 2025: Late-Breaking Data Reinforce the Prognostic Power of AI-Driven Heartflow Plaque Analysis as the Most Clinically Validated Framework for Coronary Risk Stratification

Indeterminate GlobeNewswire
George Medicines presents long-term efficacy and safety data for single pill triple combination therapy for hypertension at American Heart Association’s Scientific Sessions 2025
Nov. 9, 2025

George Medicines presents long-term efficacy and safety data for single pill triple combination therapy for hypertension at American Heart Association’s Scientific Sessions 2025

Indeterminate GlobeNewswire
Zions Bancorporation Investor News: If You Have Suffered Losses in Zions Bancorporation, N.A. (NASDAQ: ZION, ZIONP), You Are Encouraged to Contact The Rosen Law Firm About Your Rights
Nov. 9, 2025

Zions Bancorporation Investor News: If You Have Suffered Losses in Zions Bancorporation, N.A. (NASDAQ: ZION, ZIONP), You Are Encouraged to Contact The Rosen Law Firm About Your Rights

Indeterminate GlobeNewswire
CYTK SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Announces that Cytokinetics Investors Have Opportunity to Lead Class Action Lawsuit
Nov. 9, 2025

CYTK SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Announces that Cytokinetics Investors Have Opportunity to Lead Class Action Lawsuit

Indeterminate GlobeNewswire
ROSEN, A LEADING INVESTOR RIGHTS LAW FIRM, Encourages Synopsys, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - SNPS
Nov. 9, 2025

ROSEN, A LEADING INVESTOR RIGHTS LAW FIRM, Encourages Synopsys, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - SNPS

Indeterminate GlobeNewswire
TVRD SHAREHOLDER REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Tvardi Therapeutics
Nov. 9, 2025

TVRD SHAREHOLDER REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Tvardi Therapeutics

Indeterminate GlobeNewswire
SNPS SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Announces that Synopsys Investors Have Opportunity to Lead Class Action Lawsuit
Nov. 9, 2025

SNPS SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Announces that Synopsys Investors Have Opportunity to Lead Class Action Lawsuit

Indeterminate GlobeNewswire
Medera Presents Late-Breaking Data from First-In-Human Gene Therapy Trial for Heart Failure with Preserved Ejection Fraction at American Heart Association Scientific Sessions 2025
Nov. 9, 2025

Medera Presents Late-Breaking Data from First-In-Human Gene Therapy Trial for Heart Failure with Preserved Ejection Fraction at American Heart Association Scientific Sessions 2025

Indeterminate GlobeNewswire
Monopar Presents New Data and Analyses on Rapidly Improved Copper Balance in Wilson Disease Patients on Tiomolybdate Choline at AASLD - The Liver Meeting® 2025
Nov. 9, 2025

Monopar Presents New Data and Analyses on Rapidly Improved Copper Balance in Wilson Disease Patients on Tiomolybdate Choline at AASLD - The Liver Meeting® 2025

Indeterminate GlobeNewswire
JSPR SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Announces that Jasper Therapeutics Investors Have Opportunity to Lead Class Action Lawsuit
Nov. 9, 2025

JSPR SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Announces that Jasper Therapeutics Investors Have Opportunity to Lead Class Action Lawsuit

Indeterminate GlobeNewswire
ATYR SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Announces that aTyr Pharma Investors Have Opportunity to Lead Class Action Lawsuit
Nov. 9, 2025

ATYR SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Announces that aTyr Pharma Investors Have Opportunity to Lead Class Action Lawsuit

Indeterminate GlobeNewswire
WESFX SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Announces that Wildermuth Investors Have Opportunity to Lead Class Action Lawsuit
Nov. 9, 2025

WESFX SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Announces that Wildermuth Investors Have Opportunity to Lead Class Action Lawsuit

Indeterminate GlobeNewswire
MRX SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Announces that Marex Group Investors Have Opportunity to Lead Class Action Lawsuit
Nov. 9, 2025

MRX SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Announces that Marex Group Investors Have Opportunity to Lead Class Action Lawsuit

Indeterminate GlobeNewswire
MLTX SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Announces that MoonLake Investors Have Opportunity to Lead Class Action Lawsuit
Nov. 9, 2025

MLTX SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Announces that MoonLake Investors Have Opportunity to Lead Class Action Lawsuit

Indeterminate GlobeNewswire
Show More

Share us

on your social networks:
Facebook Facebook LinkedIn LinkedIn
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions